News
Bioscibex, Inkocell Therapeutics, and OrthoSens Supported By Venture Kick
Bioscibex, Inkocell Therapeutics, and OrthoSens were selected at Venture Kick’s second financial and entrepreneurial support stage and get each a CHF 40’000 support. These three Swiss Health Valley startups reshape biopharma, oncology, and orthopedic recovery. Bioscibex, Inkocell Therapeutics, and OrthoSens have progressed to the second stage of Venture Kick, securing support to drive their innovations…
Read MoreAerospec, Carewell, OptiZone and SaisiR Finalists of the PERL Prize
Four Swiss Health Valley start-ups selected from the 5 finalists in the 23rd Prix Entreprendre Lausanne Région (PERL): Aerospec, Carewell, OptiZone and SaisiR. Nearly 60 companies from the Lausanne region applied for the PERL 2025 awards. Only five have been selected for the Awards Ceremony, to be held on Wednesday 7 May, and only one…
Read MoreHealium, Hikane and LittleCubes Supported By FIT
These three new life sciences projects have each been awarded a FIT Impact grant of 10,000 CHF. Healium is developing Medicase, a compact and connected pill-dispenser designed to improve adherence to treatment. Designed for the visually impaired, Hikane is a compact device that attaches to any white cane and provides haptic feedback to signal the…
Read MoreHeroSupport Partners With Swiss Medical Network
HeroSupport, a HUG spin-off founded in 2022 by medical physicist Giovanna Dipasquale, is redefining breast cancer treatment with its 3D-printed, custom-made shells designed to improve the precision and comfort of radiotherapy. The Geneva-based startup has just announced a strategic partnership with Swiss Medical Network, a major milestone in its mission to enhance cancer care. …
Read MoreNagi Bioscience Partners With Rhino Bio Inc. To Expand In South Korea
Nagi Bioscience, a pioneering Swiss company specializing in cutting-edge laboratory technologies for alternative model organisms research, announced a strategic partnership with Rhino Bio Inc., a leading distributor for next–generation analytical systems in South Korea. The partnership accelerates Nagi Bioscience’s expansion into the South Korean market, driven by strong demand for its flagship product, SydLab™ One.…
Read MoreMoleSens Wins The EPFL Startup Champion Seed Night
On April 10th, 2025, the Startup Champions Seed Night once again confirmed its place as a cornerstone event in Western Switzerland’s innovation landscape. Co-organized by EPFL Alumni, the EPFL Vice Presidency for Innovation, and Venturelab, the 14th edition brought together nearly 500 attendees—both in person at the Rolex Forum and online—to celebrate the next generation…
Read MoreNovigenix awarded EUR 1.8 Million
Novigenix is part of the groundbreaking BRECISE IHI Consortium to industrialize AI-powered liquid biopsy for prediction of immunotherapy response. Novigenix, a Vaud-Based leader in AI-driven precision liquid biopsy solutions, has been awarded EUR 1.8M through the new BRECISE IHI grant funded by the European Union (EU) research initiative focusing on revolutionizing cancer diagnostics,…
Read More2024: A Year of Growth and Innovation at Biopôle
2024 was a landmark year for Biopôle-based companies, underscoring the campus’s reputation as a premier hub for life sciences innovation. With over CHF 246 million secured in funding, 25 new companies joining, significant commercial partnerships, and groundbreaking research advancements, Biopôle has been cultivating for 20 years a thriving ecosystem that propels healthcare and biotechnology forward.…
Read MoreProf. Li Tang Receives a Foundation Leenaards Prize
Professor Li Tang (EPFL), is exploring a new approach to overcoming the resistance of cancer cells to immunotherapeutic treatments. By strengthening the rigidity of cancer cells, the researchers hope to improve the effectiveness of T lymphocytes in eliminating tumours. This breakthrough, combining mechanical engineering, biology and clinical research, could lead to more effective treatments for…
Read MoreDr. Jasmine Abdulcadir Wins Leenaards Scientific Prize
Dr. Jasmine Abdulcadir (HUG) in collaboration with Prof. Daniel Huber (UNIGE), focuses on improving the understanding and evaluation of female genital sensitivity, a field still lacking in objective clinical tools—particularly in the context of female genital mutilation (FGM). A pioneering portable, connected device will be developed to allow women to assess the sensitivity of…
Read More